Wednesday, August 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 6, 2026

Stock market today: Dow soars 1,000 points, leading S&P 500, Nasdaq higher as Wall Street rebounds from AI tech rout

View original at finance.yahoo.com
Stock market today: Dow soars 1,000 points, leading S&P 500, Nasdaq higher as Wall Street rebounds from AI tech rout US stocks jumped on Friday, set to rebound from a weeklong tech bruising as Wall Street reassessed worries about the impact of AI disruption and the risks of hefty Big Tech spending…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • It's all going to Nvidia

    80% confidence

  • In a few short years [Caterpillar has] become the ultimate story stock. From AI/Power to infrastructure to now critical minerals, CAT touches several of the big themes that dominate the market.

    80% confidence

  • The agency will take swift action against companies mass-marketing illegal copycat drugs

    80% confidence

  • Novo Nordisk will take legal and regulatory action to protect patients, our intellectual property and the integrity of the US gold-standard drug approval framework

    80% confidence

  • Investors will likely start once again giving credit to the companies that are capturing all the profits from Big Tech's AI investments

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
Stock market today: Dow soars 1,000 points, leading S&P 500, Nasdaq higher as Wall Street rebounds from AI tech rout — Source | Via News | ViaNews Market